إعلان
إعلان
CTKB
Cytek Biosciences, Inc. Common Stock
5.45
USDبرعاية
+0.02
+0.28%
٠٩ يناير, ١٥:٥٨ UTC -5
مغلق
بعد الإغلاق
5.57
+0.13
+2.37%
تقارير أرباح CTKB
النسبة الإيجابية المفاجئة
CTKB تفوق 10 من 18 آخر التقديرات.
56%
التقرير التالي
بعد 4 أيام
بيانات التقرير القادم
١٥ يناير ٢٠٢٦
Estimate for Q4 25 (Revenue/ EPS)
$58.07M
/-$0.03
التغير الضمني من Q3 25 (Revenue/ EPS)
+11.04%
/-25.00%
التغير الضمني من Q4 24 (Revenue/ EPS)
+1.03%
/-142.86%
Cytek Biosciences, Inc. Common Stock earnings per share and revenue
On ٠٥ نوفمبر ٢٠٢٥, CTKB reported earnings of -0.04 USD per share (EPS) for Q3 25, beating the estimate of -0.05 USD, resulting in a 25.37% surprise. Revenue reached 52.29 مليون, compared to an expected 52.52 مليون, with a -0.43% difference. The market reacted with a +13.22% price change (close before vs. close after earnings).
Looking ahead to Q4 25, 7 المحللين forecast an EPS of -0.03 USD, with revenue projected to reach 58.07 مليون USD, implying an نقصان of -25.00% EPS, and زيادة of 11.04% in Revenue from the last quarter.
الأسئلة الشائعة
What were Cytek Biosciences, Inc. Common Stock's earnings and revenue for the latest quarter Q3 2025?
For Q3 2025, Cytek Biosciences, Inc. Common Stock reported EPS of -$0.04, beating estimates by 25.37%, and revenue of $52.29M, -0.43% below expectations.
How did the market react to Cytek Biosciences, Inc. Common Stock's Q3 2025 earnings?
The stock price moved up 13.22%, changed from $4.01 before the earnings release to $4.54 the day after.
When is Cytek Biosciences, Inc. Common Stock expected to report next?
The next earning report is scheduled for ١٥ يناير ٢٠٢٦.
What are the forecasts for Cytek Biosciences, Inc. Common Stock's next earnings report?
Based on 7
المحللين, Cytek Biosciences, Inc. Common Stock is expected to report EPS of -$0.03 and revenue of $58.07M for Q4 2025.
Which companies are reporting earnings today?
شيك FXEmpire's Earnings Calendar for today's list of reporting companies.
إعلان